194TiPPhase III study of [fam-] trastuzumab deruxtecan (DS-8201a) vs T-DM1 for HER2-positive breast cancer
Verma, S, Shahidi, J, Lee, C, Wang, K, Cortes, JVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz100.045
Date:
May, 2019
File:
PDF, 79 KB
2019